SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-018109
Filing Date
2021-07-29
Accepted
2021-07-29 17:12:43
Documents
14
Period of Report
2021-07-23
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 66607
2 ex99-1.htm EX-99.1 28152
3 ex99-1_1.jpg GRAPHIC 3551
  Complete submission text file 0001493152-21-018109.txt   281841

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ntec-20210723.xsd EX-101.SCH 3033
5 XBRL LABEL FILE ntec-20210723_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE ntec-20210723_pre.xml EX-101.PRE 22364
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3419
Mailing Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512
Business Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512 97225864657
Intec Pharma Ltd. (Filer) CIK: 0001638381 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37521 | Film No.: 211128529
SIC: 2834 Pharmaceutical Preparations